Page last updated: 2024-08-18

thiophenes and aspartic acid

thiophenes has been researched along with aspartic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Echevarria, E; Hughes, J; Hunter, JC; Robles, L; Tortella, FC1
Allen, DA; Burdett, MT; Choong, IC; DeLano, WL; Erlanson, DA; Fahr, B; Gordon, EM; Lam, JW; Lee, D; Lew, W; Luong, TN; McDowell, RS; O'Brien, T; Pham, P; Wiesmann, C1
Erbe, DV; Follows, BC; Joseph-McCarthy, D; Lee, J; Wan, ZK; Xu, W; Zhang, YL1
Guan, H; He, Z; Zhou, P; Zhou, X1
Chen, X; Huang, L; Jia, Y; Ling, X; Liu, S; Wang, Y; Xu, G1
Bong, D; Floyd, C; Liao, S; Pino, MJ; Tan, K; Wu, C1

Trials

1 trial(s) available for thiophenes and aspartic acid

ArticleYear
Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment.
    Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:11

    Topics: Adolescent; Adult; Antidepressive Agents; Aspartic Acid; Case-Control Studies; Choline; Creatine; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Hippocampus; Humans; Hydrocortisone; Magnetic Resonance Spectroscopy; Male; Middle Aged; Thiophenes; Young Adult

2012

Other Studies

5 other study(ies) available for thiophenes and aspartic acid

ArticleYear
PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats.
    Life sciences, 1990, Volume: 46, Issue:17

    Topics: Animals; Anticonvulsants; Aspartic Acid; Dose-Response Relationship, Drug; Electroshock; Flurothyl; Male; N-Methylaspartate; Pyrroles; Random Allocation; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Thiophenes; Time Factors

1990
Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design.
    Journal of medicinal chemistry, 2002, Nov-07, Volume: 45, Issue:23

    Topics: Aspartic Acid; Benzoxazoles; Binding Sites; Caspase 3; Caspase Inhibitors; Caspases; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Fluorenes; Humans; Protein Binding; Salicylates; Sulfonamides; Thiophenes

2002
Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.
    Bioorganic & medicinal chemistry letters, 2006, Sep-15, Volume: 16, Issue:18

    Topics: Aspartic Acid; Crystallography, X-Ray; Cyclization; Enzyme Inhibitors; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Structure-Activity Relationship; Thiophenes

2006
Sensitive and selective detection of aspartic acid and glutamic acid based on polythiophene-gold nanoparticles composite.
    Talanta, 2008, Oct-19, Volume: 77, Issue:1

    Topics: Aspartic Acid; Glutamic Acid; Gold; Metal Nanoparticles; Microscopy, Electron, Transmission; Molecular Structure; Polymers; Reproducibility of Results; Sensitivity and Specificity; Solutions; Spectrophotometry; Thiophenes

2008
Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
    Life sciences, 2021, Mar-15, Volume: 269

    Topics: Allosteric Regulation; Animals; Aspartic Acid; Cluster Analysis; Conserved Sequence; Crystallization; Humans; Ligands; Mice; Molecular Dynamics Simulation; Morphine; Principal Component Analysis; Protein Conformation; Receptors, Opioid, mu; Signal Transduction; Structural Homology, Protein; Thiophenes; Tyrosine; Urea; Water

2021